Condition: Benign Prostatic Hyperplasia · Sponsor: Urotronic Inc.
PINNACLE is a prospective, multi-center, randomized control clinical trial to establish the safety and efficacy of the Optilume™ BPH Catheter System in the treatment of benign prostatic hyperplasia (BPH)
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arkansas Urology | Little Rock, Arkansas, United States | — |
| Colorado Clinical Research | Golden, Colorado, United States | — |
| Advanced Urology Institute | Daytona Beach, Florida, United States | — |
| Florida Urology Partners | Tampa, Florida, United States | — |
| Comprehensive Urologic Care | Lake Barrington, Illinois, United States | — |
| Regional Urology, LLC | Shreveport, Louisiana, United States | — |
| Chesapeake Urology Research Associates | Hanover, Maryland, United States | — |
| Chesapeake Urology Research Associates | Towson, Maryland, United States | — |
| Sheldon Freedman MD, Ltd | Las Vegas, Nevada, United States | — |
| New Jersey Urology | Englewood, New Jersey, United States | — |
| AccuMed Research Associates | Garden City, New York, United States | — |
| Manhattan Medical Research Practice, PLLC | New York, New York, United States | — |
+ 9 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.